We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Fundamental aspects
-
1. Inflammation and tissue homeostasis
- Prof. Herman Waldmann
-
2. Introduction to the immune system
- Prof. Herman Waldmann
-
3. Hematopoiesis: the making of an immune system
- Prof. Paul J. Fairchild
-
4. Inflammation: purposes, mechanisms and development
- Prof. Pietro Ghezzi
-
5. Phagocytosis
- Dr. Eileen Uribe-Querol
-
6. Regulated cell death mechanisms and their crosstalk with the immune system 1
- Dr. Luis Alberto Baena-Lopez
-
7. Regulated cell death mechanisms and their crosstalk with the immune system 2
- Dr. Luis Alberto Baena-Lopez
- Innate immunity
-
11. Cells of the innate immune system
- Prof. Kevin Maloy
-
12. Microbial recognition and the immune response
- Dr. Dana Philpott
-
13. Toll-like receptor signalling during infection and inflammation
- Prof. Luke O'Neill
- Intercellular mediators
-
14. Chemokines
- Dr. James E. Pease
-
15. Cytokines
- Prof. Iain McInnes
-
16. IL-1 family cytokines as the canonical DAMPs of the immune system
- Prof. Seamus Martin
-
17. Glycans at the frontiers of inflammation, autoimmunity and cancer
- Prof. Salomé S. Pinho
-
18. Glycoimmunology
- Prof. Paula Videira
- Adaptive immunity B cells
-
21. Antigen recognition in the immune system
- Prof. Herman Waldmann
-
22. B cell biology
- Prof. Richard Cornall
-
23. Antibody structure and function: antibody structure
- Dr. Mike Clark
-
24. Antibody structure and function: antibody function
- Dr. Mike Clark
-
25. Antibody genes and diversity
- Dr. Mike Clark
-
26. In vivo antibody discovery and hybridoma technology
- Prof. Dr. Katja Hanack
-
27. Antibody engineering: beginnings to bispecifics and beyond
- Dr. Ian Wilkinson
-
29. The immunobiology of Fc receptors
- Prof. Mark Cragg
-
30. Immunoreceptors
- Prof. Anton van der Merwe
-
31. Affinity, avidity and kinetics in immune recognition
- Prof. Anton van der Merwe
- Adaptive immunity T cells
-
32. The thymus and T cell development: a primer
- Prof. Georg Holländer
-
33. Lineage decisions in the thymus: T cell lineage commitment
- Prof. Bruno Silva-Santos
-
34. Lineage decisions in the thymus: αβ and γδ T cell lineages
- Prof. Bruno Silva-Santos
-
35. CD4 T cell subsets
- Dr. Brigitta Stockinger
-
36. Cytotoxic T lymphocytes
- Prof. Gillian M. Griffiths
-
37. Gamma delta T-cells
- Prof. Bruno Silva-Santos
-
38. Tfh and Tfr cells
- Prof. Luis Graca
-
39. Tissue resident memory T cells (TRM)
- Dr. Marc Veldhoen
-
40. Mathematical modeling in immunology
- Prof. Ruy M. Ribeiro
- The importance of the MHC in immunity
-
41. The MHC and MHC molecules 1
- Prof. Jim Kaufman
-
42. The MHC and MHC molecules 2
- Prof. Jim Kaufman
-
43. Natural killer cells
- Dr. Philippa Kennedy
-
44. Human NK cells
- Prof. Lorenzo Moretta
-
46. NK cells in viral immunity
- Prof. Lewis Lanier
- Lymphocyte activation
-
47. Signal transduction by leukocyte receptors
- Dr. Omer Dushek
-
48. Immunological memory 1
- Prof. David Gray
-
49. Immunological memory 2
- Prof. David Gray
-
50. Studying immune responses “one cell at a time”
- Dr. Mir-Farzin Mashreghi
- Major cellular partners in immunity
-
51. The mononuclear phagocyte system - tissue resident macrophages: distribution and functions
- Prof. Emeritus Siamon Gordon
-
52. The mononuclear phagocyte system: tissue resident macrophages - activation and regulation
- Prof. Emeritus Siamon Gordon
-
53. Dendritic cells: professional antigen presenting cells
- Prof. Paul J. Fairchild
-
54. Mucosal immunology
- Prof. Daniel Mucida
- Immunological tolerance and regulation
-
55. Self-tolerance
- Prof. Herman Waldmann
-
56. Tolerance and autoimmunity
- Prof. Emerita Anne Cooke
-
57. The balance between intestinal immune homeostasis and inflammation
- Prof. Dr. Janneke Samsom
- Translational immunology - immune deficiency
-
58. Primary immunodeficiency disorders
- Dr. Smita Y. Patel
-
59. Changes in innate and adaptive immunity during human ageing 1
- Dr. Roel De Maeyer
-
60. Changes in innate and adaptive immunity during human ageing 2
- Dr. Roel De Maeyer
-
61. The aging immune system
- Prof. Ana Caetano
- Translational immunology - protection against pathogenic microbes
-
62. Immune responses to viruses
- Prof. Paul Klenerman
-
63. HIV and the immune system
- Prof. Quentin Sattentau
-
64. COVID-19: the anti-viral immune response
- Prof. Danny Altmann
-
65. Bacterial immune evasion
- Prof. Christoph Tang
-
66. The immunology underlying tuberculosis
- Prof. Thomas R. Hawn
-
67. Innate immunity to fungi
- Prof. Gordon D. Brown
-
68. Parasite immunity: introduction and Plasmodium
- Dr. Catarina Gadelha
-
69. Parasite immunity: Leishmania and Schistosoma
- Dr. Catarina Gadelha
-
70. Vaccination
- Dr. Anita Milicic
-
71. The history of vaccines 1
- Prof. Emeritus Anthony R. Rees
-
72. The history of vaccines 2
- Prof. Emeritus Anthony R. Rees
-
73. The history of vaccines 3
- Prof. Emeritus Anthony R. Rees
-
74. The science of vaccine adjuvants
- Dr. Derek O'Hagan
- Translational immunology - hypersensitivity, autoimmune disease and their management
-
75. Hypersensitivity diseases: type 1 hypersensitivity
- Prof. Herman Waldmann
-
76. Innate lymphoid cells in allergy
- Prof. Emeritus Shigeo Koyasu
-
77. Hypersensitivity diseases: type II-IV hypersensitivity
- Prof. Sara Marshall
-
78. Immune memory underlying lifelong peanut allergy
- Dr. Kelly Bruton
-
79. Memory B cells in allergy: B cell activation and response
- Dr. Kelly Bruton
-
80. Memory B cells in allergy: ontogeny, phenotype and plasticity
- Dr. Kelly Bruton
-
81. B cells at the crossroads of autoimmune diseases
- Dr. Xiang Lin
-
82. Interleukin-17: from clone to clinic
- Prof. Leonie Taams
-
83. Autoimmunity and type 1 diabetes
- Prof. Emerita Anne Cooke
-
84. What is new in type 1 diabetes?
- Prof. Åke Lernmark
-
85. Antibodies to control or prevent type 1 diabetes
- Dr. Robert Hilbrands
-
86. Monoclonal antibodies in haemato-oncology
- Prof. Mark Cragg
-
87. Therapeutic antibodies
- Dr. Geoffrey Hale
-
88. Endothelial cells: regulators of autoimmune-neuroinflammation
- Dr. Laure Garnier
-
89. Neuroimmunometabolism
- Prof. Ana Domingos
-
90. The immunology of multiple sclerosis
- Dr. Joanne Jones
-
91. Immunology of the peripheral nervous system: the inflammatory neuropathies
- Dr. Simon Rinaldi
-
92. Ocular immunology: an overview of immune mechanisms operating in the eye
- Dr. Eleftherios Agorogiannis
-
93. Understanding myasthenia gravis and advances in its management
- Prof. Henry J. Kaminski
-
94. The immunology underlying rheumatic diseases
- Dr. Hussein Al-Mossawi
-
96. Complement and lupus
- Prof. Marina Botto
-
97. Immune mechanisms in liver diseases
- Prof. Paul Klenerman
- Translational immunology - transplantation immunology
-
98. Principles of transplantation: overview of the immune response
- Prof. Emerita Kathryn Wood
-
99. Factors influencing outcomes in clinical transplantation 1
- Prof. Emerita Kathryn Wood
-
100. Factors influencing outcomes in clinical transplantation 2
- Prof. Emerita Kathryn Wood
- Translational immunology - cancer immunology
-
101. Cancer immunology
- Prof. Tim Elliott
-
102. Cancer immunotherapy
- Prof. Tim Elliott
-
103. Myeloid-derived suppressor cells in cancer
- Prof. Dmitry Gabrilovich
-
104. IL-2 in the immunotherapy of autoimmunity and cancer
- Prof. Thomas Malek
-
105. Latest advances in the development of CAR & TCR T-cell treatments for solid tumours
- Dr. Else Marit Inderberg
Printable Handouts
Navigable Slide Index
- Introduction
- FcRs bind the Fc domain of antibodies
- Types of mouse FcRs
- Cell expression of mouse FcRs
- Types of human FcRs
- Cell expression of human FcRs
- FcγRs: a family of related receptors that bind IgG
- FcγRs: affinity for IgG
- FcγRs: paralogous system in mice
- FcγRs: IgG binding is regulated by carbohydrate
- FcγR regulate many facets of the immune response
- FcγRII regulates many facets of the immune response
- ITAM vs ITIM Signaling through FcγR
- Consequences of FcγR ligation on NK cells
- Consequences of FcγR ligation on B cells
- Consequences of FcγR ligation on additional immune cells
- Cellular modulation of FcγR respons
- Genetic modulation of FcγR response
- Human FcγR are polymorphic and have copy number variation
- Isotype modulation of FcγR response
- mAb isotype dictates FcγR binding
- hAb isotype dictates FcγR binding
- The antibody revolution
- Currently approved mAbs for cancer
- How do direct targeting mAb work?
- Importance of FcγR (1)
- Importance of FcγR (2)
- Evidence for the importance of FcγR in mAb therapy (1)
- Evidence for the importance of FcγR in mAb therapy (2)
- Evidence for the importance of FcγR in mAb therapy (3)
- Direct targeting mAb
- Improving FcγR effector functions
- Improving effector functions using fucosylation
- Impact of glyco-engineering on OBZ
- Structural basis for enhanced affinity of glycoengineered antibodies for FcγRIIIa
- OBZ exhibits up to 100-fold higher ADCC potency than rituximab and ofatumumab
- Summary of mAb therapeutics
- Interaction of immunomodulatory mAb with FcγR
- Immunomodulatory mAb
- Two classes of Immunomodulatory mAbs
- Both classes of immunomodulatory mAbs can be therapeutic
- Optimal isotypes of checkpoint mAbs differ
- Contrasting isotype requirements for immune stimulatory mAb
- The role of FcγRIIb is in crosslinking
- Mechanism of agonistic anti-TNFR mAb
- Summary
- Thank you
Topics Covered
- Cellular expression and function of Fc gamma receptors (FcγRs)
- IgG binding to FcγRs is modulated by carbohydrates
- The consequences of FcγR ligation in immune cells is cell type specific
- Roles of FcγRs in sculpting in the humoral immune response
- FcγRs is a key regulator in antibody immunotherapy
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Cragg, M. (2021, January 31). The immunobiology of Fc receptors [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved February 5, 2025, from https://doi.org/10.69645/XVMF9971.Export Citation (RIS)
Publication History
Financial Disclosures
- Mark Cragg is a retained consultant for BioInvent International and has performed educational and advisory roles for Baxalta and Boehringer Ingleheim. He has received research funding from Roche, Gilead, Bioinvent International and GSK.
A selection of talks on Biochemistry
Transcript
Please wait while the transcript is being prepared...
0:00
I'm Professor Mark Cragg.
I'm a professor of experimental cancer biology at the Antibody and Vaccine
Group in the Centre of Cancer Immunology in the University of Southampton.
The talk that I'm going to give today is around the immunobiology of Fc receptors.
0:16
Fc receptors bind the Fc domain of antibodies.
I'm sure you're all aware of the structure of an antibody.
It's this Y-shaped molecule which has Fab domains
which do the binding of the antibody,
which bind to different epitopes and antigens,
which carry the variable regions,
whereas we also have the stem part of
the antibody molecule, known as the Fc or fragment crystallizable.
It's that fragment crystallizable,
the Fc domain, which is bound by Fc receptors.
Importantly, Fc receptors are able to bind to different classes of antibody.
You can see that there are a number of different classes of antibody, IgA, D,
E, G, and M, and each of them have different functions within the immune system.
For example, IgA protects mucous membranes,
whereas IgM is a key component of the primary immune response,
and IgG of the secondary antibody response.
But it's important to recognise that several of
their key functions are actually mediated by Fc receptors.
1:20
In the mouse system,
there are a whole host of
Fc receptors that can bind to those different antibody molecules.
There are a whole series which are isotype-specific.
For example, a polyIgR is
an Fc receptor which can bind to IgM molecules and also IgA molecules.
In contrast, we have receptors such as Fc epsilon receptor I (FcεRI) and Fc epsilon receptor II (FcεRII),
which bind only to IgE molecules.
We also have a whole series of receptors which bind to the Fc gamma receptors,
which bind to IgG,
and I'm going to be spending a lot of time talking about those in the later slides.
It's also important to say that there's an intracellular Fc receptor called TRIM21,
which binds antibodies when they've been internalised
(after they have bound to viruses
for instance), and that stimulates an antiviral response.
But we're not going to get into that particular Fc receptor in any great detail.